» Articles » PMID: 30201069

[Advances in Surgical Approach and Resection of Non-small Cell Lung Cancer]

Overview
Date 2018 Sep 12
PMID 30201069
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

With the change of the spectrum of disease, the incidence and mortality of non-small cell lung cancer (NSCLC) has been high in global scale, since surgical intervention was applied to treat lung cancer, its status is increasing day by day, at present comprehensive treatment leaded by surgery has become the preferred scheme for NSCLC, there are many different kinds of surgical approaches and operation methods of disease, and the new technologies appear constantly, the paper aim to summarize the research progress of different operationmethods and surgical approach. With the development of software and hardware technology and the concept of minimally invasive thoracoscopic surgery was received by more people, minimally invasive thoracoscopic surgery has brought more benifit than traditional thoracotomy for lung cancer patients, minimally invasive thoracoscopic surgery reserve more lung tissue and improve the survival quality of patients due to better pulmonary function, we believe that minimally invasive thoracoscopic surgery can bring more benefits to people with surgical indications and surgical procedure further standardization.
.

Citing Articles

Early ambulation and postoperative recovery of patients with lung cancer under thoracoscopic surgery-an observational study.

Ding X, Zhang H, Liu H J Cardiothorac Surg. 2023; 18(1):136.

PMID: 37041603 PMC: 10091666. DOI: 10.1186/s13019-023-02263-9.


Postoperative delirium and its influencing factors in elderly patients with lung cancer in the intensive care unit.

Lu Y, Liu X J Thorac Dis. 2023; 15(2):701-710.

PMID: 36910101 PMC: 9992628. DOI: 10.21037/jtd-23-259.


Modified Sijunzi Decoction Inhibits Epithelial-Mesenchymal Transition of Non-Small Cell Lung Cancer by Attenuating AKT/GSK3β Pathway and .

Shao N, Xiao Y, Zhang J, Zhu Y, Wang S, Bao S Front Pharmacol. 2022; 12:821567.

PMID: 35111070 PMC: 8802809. DOI: 10.3389/fphar.2021.821567.

References
1.
Ambrogi M, Fanucchi O, Melfi F, Mussi A . Robotic surgery for lung cancer. Korean J Thorac Cardiovasc Surg. 2014; 47(3):201-10. PMC: 4157469. DOI: 10.5090/kjtcs.2014.47.3.201. View

2.
Ramadan O, Wei B, Cerfolio R . Robotic surgery for lung resections-total port approach: advantages and disadvantages. J Vis Surg. 2017; 3:22. PMC: 5637951. DOI: 10.21037/jovs.2017.01.06. View

3.
Ginsberg R, Rubinstein L . Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995; 60(3):615-22; discussion 622-3. DOI: 10.1016/0003-4975(95)00537-u. View

4.
Bendixen M, Jorgensen O, Kronborg C, Andersen C, Licht P . Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial. Lancet Oncol. 2016; 17(6):836-844. DOI: 10.1016/S1470-2045(16)00173-X. View

5.
Aokage K, Yoshida J, Hishida T, Tsuboi M, Saji H, Okada M . Limited resection for early-stage non-small cell lung cancer as function-preserving radical surgery: a review. Jpn J Clin Oncol. 2016; 47(1):7-11. DOI: 10.1093/jjco/hyw148. View